Skip to main content

Table 1 BMFS patient characteristics

From: 18F-FLT PET/MRI for bone marrow failure syndrome-initial experience

Patient

Age

Sex

Diagnosis

WBC

Hb

Plt

Bone marrow

FLT-SUV

DWI

Progress

(× 103/μL)

(g/dL)

(×103/μL)

biopsy

Ilium

Lumbar

Sternum

Score

1

88

M

Non-severe AA

5

7.1

113

Hypocellular

3.7

8.9

6.5

1

 

2

63

F

Non-severe AA

2.4

12

64

Hypocellular

1.6

7.8

8.2

1

 

3

81

M

Non-severe AA

1.9

5.1

117

Hypocellular

0.4

4.9

1.2

1

 

4

24

F

Non-severe AA

2

11

12

Hypocellular

0.2

14.2

13.7

1

 

5

79

M

Non-severe AA

2.7

10.3

35

Hypocellular

1

7.8

14.7

2

 

6

66

F

Severe AA

1

5.2

25

Hypocellular

0.9

4.1

3.9

1

 

7

67

M

Severe AA

3.1

5.6

4

Hypocellular

0.3

0.5

3.2

1

 

8

70

M

MDS

1.3

5.8

34

Normocellular

7.9

11.4

13.9

1

 

9

66

M

MDS

1.6

8.4

47

Normocellular

7.8

12.1

10.1

1

 

10

80

M

MDS

3

6.8

105

Hypercellular

8.6

11.5

9.2

2

AML

11

68

F

MDS

7

6

13

Hypercellular

9.4

9.5

9.7

1

AML

12

68

M

MDS

1

7.2

26

Normocellular

5.1

5.3

7.1

1

AML

13

66

M

MDS

8.6

11.1

112

Normocellular

5

6.4

6.5

2

 

14

65

F

MDS

2.5

7.1

37

Hypercellular

11.5

13

16.5

1

 

15

81

F

MDS

6.3

10

74

Hypercellular

7.4

9.9

9.8

3

 

16

18

M

hypo-MDS

0.8

7.5

121

Hypocellular

2.9

9.7

8.3

1

 

17

77

M

hypo-MDS

1.7

8.3

20

Hypocellular

2.1

7.8

1.3

1

AML

18

68

M

hypo-MDS

3

10

133

Hypocellular

1.2

3

6.2

2

 

19

72

M

hypo-MDS

1.5

9.9

5

Hypocellular

1

3.3

4.6

2

 

20

60

M

hypo-MDS

1.3

8.3

154

Hypocellular

3.1

3.5

4.7

1

AML

21

75

M

hypo-MDS

2.5

12

36

Hypocellular

1.6

2.8

8.8

1

 

22

81

M

hypo-MDS

2.5

8.3

39

Hypocellular

1.7

5.6

3.5

2

AML

23

90

M

hypo-MDS

2.7

7.9

319

Normocellular

3.1

6.1

7.5

2

 

24

69

M

MPN (primary MF)

7

11.6

14

Normocellular

2.7

4.7

4

3

 

25

70

M

MPN (secondary MF)

19.5

11.2

438

Hypercellular

9.5

16

15.1

3

 
  1. M male, F female, AA aplastic anemia, MPN myeloproliferative neoplasms, MF myelofibrosis, MDS myelodysplastic syndrome, AML acute myeloid leukemia, WBC white blood cell, Hb hemoglobin, and Plt platelet count